【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Product profiles
PART 04: Market research methodology
• Research methodology
• Economic indicators
PART 05: Introduction
• Key market highlights
PART 06: Disease overview
• Understanding the disease
• Types of psoriatic arthritis
• Symptoms
• Risk factors
• Diagnosis
• Disease management
• Quality of life
• Epidemiology
PART 07: Pipeline portfolio
PART 08: Novel mechanisms targeted by pipeline candidates
• Small molecules
• Biologics
PART 09: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 10: Market segmentation by MoA
• TNF-alpha inhibitors
• PDE4 inhibitors
• IL blockers
• Others
PART 11: Market segmentation by type of molecule
• Biologics
• Small molecules
PART 12: Market segmentation by severity of disease
PART 13: Market segmentation by route of administration
• Oral
• Parenteral
• Topical
PART 14: Market segmentation by dosage form
• Solid
• Liquid
• Semi-solid
PART 15: Geographical segmentation
• Psoriatic arthritis market in Americas
• Psoriatic arthritis market in EMEA
• Psoriatic arthritis market in APAC
PART 16: Market drivers
• Increase in public awareness
• Unmet medical needs
• Growing patient population
• Change in lifestyle patterns
PART 17: Impact of drivers
PART 18: Market challenges
• Increasing costs of biologics
• Loss of patent exclusivity of branded therapies
• Use of CAM by patients
• Adverse effects of drugs
PART 19: Impact of drivers and challenges
PART 20: Market trends
• Emergence of biosimilars
• Popularity of off-label and traditional treatment options
• Patient assistance programs in the US
• Dominance of market by biologics
PART 21: Vendor landscape
• Competitive scenario
• Market share analysis 2014
• Other prominent vendors
PART 22: Key vendor analysis
• AbbVie
• Amgen
• Celgene
• Janssen Pharmaceuticals
• UCB
PART 23: Appendix
• List of abbreviations
PART 24: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Types of psoriatic arthritis
Exhibit 03: Signs and symptoms of psoriatic arthritis
Exhibit 04: Risk factors for psoriatic arthritis
Exhibit 05: Diagnostic test for psoriatic arthritis
Exhibit 06: Treatment options for psoriatic arthritis
Exhibit 07: Management of psoriatic arthritis
Exhibit 08: Pipeline molecules for psoriatic arthritis
Exhibit 09: Psoriatic arthritis clinical trial by phase
Exhibit 10: Psoriatic arthritis clinical trial by status
Exhibit 11: Novel targets of the pipeline candidates
Exhibit 12: Tofacitinib
Exhibit 13: Ixekizumab
Exhibit 14: Sekukinumab
Exhibit 15: Bimekizumab
Exhibit 16: Global psoriatic arthritis market 2014-2019 ($ millions)
Exhibit 17: Five forces analysis
Exhibit 18: Segmentation of global psoriatic arthritis market by MoA
Exhibit 19: Segmentation of global psoriatic arthritis market by MoA 2014
Exhibit 20: Segmentation of global psoriatic arthritis market by type of molecule
Exhibit 21: Segmentation of global psoriatic arthritis market by severity of disease
Exhibit 22: Segmentation of global psoriatic arthritis market by route of administration
Exhibit 23: Segmentation of global psoriatic arthritis market by dosage form
Exhibit 24: Global psoriatic arthritis market by geography 2014
Exhibit 25: Psoriatic arthritis market in Americas 2014-2019 ($ millions)
Exhibit 26: Psoriatic arthritis market in EMEA 2014-2019 ($ millions)
Exhibit 27: Psoriatic arthritis market in APAC 2014-2019 ($ millions)
Exhibit 28: Global psoriatic arthritis market by geography 2014-2019 ($ millions)
Exhibit 29: Drivers in global psoriatic arthritis market
Exhibit 30: Impact of drivers
Exhibit 31: Challenges in global psoriatic arthritis market
Exhibit 32: Average annual cost of HUMIRA, Enbrel, and Remicade 2014 ($)
Exhibit 33: Approvals and patent expiries of branded biologics
Exhibit 34: Impact of drivers and challenges
Exhibit 35: Trends in global psoriatic arthritis market
Exhibit 36: YoY sales comparison of top drugs 2010-2014 ($ millions)
Exhibit 37: YoY sales comparison of top drugs 2010-2014 (%)
Exhibit 38: YoY global sales of HUMIRA 2010-2014 ($ millions)
Exhibit 39: AbbVie: Key takeaways
Exhibit 40: YoY global sales of Remicade 2010-2014 ($ millions)
Exhibit 41: YoY global sales of Simponi 2012-2014 ($ millions)
Exhibit 42: Janssen Pharmaceuticals: Key takeaways
Exhibit 43: YoY sales of Enbrel in US and Canada 2010-2014 (($ millions)
Exhibit 44: YoY sales of Enbrel in US 2010-2014 ($ millions)
Exhibit 45: YoY sales of Enbrel in Canada 2010-2014 ($ millions)
Exhibit 46: YoY sales of Enbrel in Japan 2010-2014 ($ millions)
Exhibit 47: Comparison of YoY sales of Enbrel in US, Japan, and Canada 2010-2014 ($ millions)
Exhibit 48: Amgen: Key takeaways
Exhibit 49: UCB: Key takeaways
Exhibit 50: Celgene: Key takeaways
Exhibit 51: AbbVie: Product segmentation by revenue 2014
Exhibit 52: AbbVie: Geographical segmentation by revenue 2014
Exhibit 53: Amgen: Business segmentation by revenue 2014
Exhibit 54: Amgen: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 55: Amgen: Geographical segmentation by revenue 2014
Exhibit 56: Celgene: Product segmentation by revenue 2014
Exhibit 57: Celgene: Product segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 58: Celgene: Geographical segmentation by revenue 2014
Exhibit 59: Janssen Pharmaceuticals: Key therapeutic areas
Exhibit 60: UCB: Product segmentation by revenue 2014
Exhibit 61: UCB: Product segmentation by revenue 2013 and 2014
Exhibit 62: UCB: Geographical segmentation by revenue 2014
Exhibit 63: Geographical segmentation by revenue 2013 and 2014
【レポート販売概要】
■ タイトル：乾癬性関節炎治療薬の世界市場2015-2019■ 英文：Global Psoriatic Arthritis Market 2015-2019
■ 発行日：2015年12月16日
■ 調査会社：Technavio
■ 商品コード：IRTNTR7499
■ 調査対象地域：世界
- 2014年日本の分子血液型・分類検査および感染症NAT（核酸増幅検査）市場Complete report $7,700. DataPack (test volumes, sales forecasts, supplier shares) $4,950. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Japanese molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development a …
- ディスプレイドライバーの世界市場予測（～2023年）“Increasing demand for OLED and flexible displays and highly priced and advanced display drivers are driving the display driver market toward significant growth”The display driver market is estimated to grow from USD 7.1 billion in 2018 to USD 9.1 billion by 2023, at a CAGR of 5.1% between 2018 and 2023. Growth in the use of 4K and 8K televisions and availability of UHD content, and evolving role …
- アンモニア、無水・水溶液市場：インドThis report is a comprehensive research of ammonia, anhydrous and in aqueous solution market in India. The report starts with giving brief country profile for India, including general information and main economic indicators. Further, the report provides in-depth analyses ammonia, anhydrous and in aqueous solution market in the country. It identifies key market players, including major producers, …
- 自動車用静圧式ファンドライブの世界市場予測（～2025年）The hydrostatic fan drive system market for automotive is projected to grow at a CAGR of 6.80% from 2018 to 2025. The market for automotive hydrostatic fan drive systems is estimated to be USD 144.8 Million in 2018 and is projected to reach USD 229.6 Million by 2025. The key growth drivers of this market are the growing demand for an independent, compact, and silent engine cooling system for off-h …
- ガラクトオリゴ糖（GOS）の世界市場の動向分析：用途別（食品･飲料、栄養補助食品）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）、セグメント予測、2014-2025The global galacto-oligosaccharide (GOS) market is expected to reach a market size of USD 1.69 billion by 2025, according to a new report by Grand View Research, Inc. Changing consumer lifestyles coupled with increasing number of working women in the developing economies is likely to have a positive impact on the market growth over the forecast period. GOS is used as low-calorie sweetener & food i …
- 末梢血管インターベンション機器の世界市場：企業動向Peripheral Vascular Interventions - Current and Future Players Summary The peripheral vascular interventions market is a dynamic, billion-dollar market with solid growth potential through 2022. Recent advancements in this field have greatly expanded the potential of therapeutic applications. The market for peripheral vascular interventions including lower extremity stents, percutaneous translumina …
- 人工心臓弁の世界市場：機械式心臓弁、経カテーテル心臓弁、組織心臓弁This report on the global prosthetic heart valve market has been analysed and segmented on the basis of product and geography. It analyzes the competitive developments, such as alliance, joint venture, and merger & acquisition in the global market. This market has also been analyzed with an explicit focus on the high-growth applications and fastest-growing market segments. A prosthetic heart valve …
- ペンニードルの世界市場：種類、長さ、治療、購入、地域別分析The pen needles market is expected to reach USD 2.81 Billion by 2021 from USD 1.65 Billion in 2016, growing at a CAGR of 11.2% from 2016 to 2021. The market is segmented on the basis of type, needle length, therapy, and mode of purchase. By type, the market is categorized into standard and safety pen needles. The standard pen needles segment is expected to account for the largest share of the mark …
- 世界の細胞分析市場動向と予測（～2018）The global cell analysis market is a technology-driven market and is marked by the ‘Threat of Obsolescence,’ wherein technologies as well as their adoption by end users changes very rapidly. Hospitals, academic and government institutes, as well as pharmaceutical and biotechnology companies are increasing their focus on using cell analysis as a powerful research tool in research, drug discovery, a …
- オピオイド誘発性腸機能障害：グローバル臨床試験レビュー（2014年上半期）Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014" provides data on the Opioid Induced Bowel Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Opioid Induced Bowel Dysfunction. It inclu …
- 運動維持手術の世界市場：人工椎間板、人工腰椎板、椎間スペーサーAbout Motion Preservation Surgery Motion preservation surgery helps preserve the motion of the disc space and is an alternative to fusion techniques such as plates and screws or bone grafts, whichrestrict motion. Artificial discs reduce degeneration of adjacent segments of the cervical spine and lumbar, maintain normal neck motion, and ensure faster return to normal activity. Motion preservation i …
- 世界のモノのインターネット(IoT) 及びM2M通信市場動向及び予測(2014 – 2019)Internet of Things (IoT) and Machine-to-Machine (M2M) communication are the essence of the smart productivity and living. IoT and M2M is a worldwide network of interconnected objects. With full of dynamicity, the objects can interact anywhere and anytime and can interoperate and collaborate heterogeneous range of entities. It is expected that by 2025 a trillion of interconnected devices will be pr …
- 世界のトップ幹細胞企業分析：アメリカ、ヨーロッパ、イスラエル、アジアLeading Stem Cell Companies – Discover What Their Futures Hold, Benefiting Your Reputation for Commercial InsightWho are the leading stem cell developers and producers? And what are their sales outlooks? Visiongain’s updated report shows you their activities and potentials from 2016. There you discover therapies, results, trends in research and development, opportunities and revenue forecasts. Tha …
- 子宮内膜症(Endometriosis)の治療薬パイプライン動向（2015年上半期版）Endometriosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2015’, provides an overview of the Endometriosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA) …
- カラーマスターバッチの世界市場予測（～2021）The market size of color masterbatch is projected to reach USD 4.75 Billion by 2021, registering a CAGR of 5.6% between 2016 and 2021. The rapid growth in the packaging industry in Asia-Pacific is a key driver of the color masterbatch market. Packaging is the dominating industry in the market. It is widely used for industrial and household purposes. Improved lifestyle and globalization have trigge …
